Wed, July 31, 2024
Tue, July 30, 2024
Mon, July 29, 2024

Jason Zemansky Maintained (SNDX) at Strong Buy with Decreased Target to $30 on, Jul 30th, 2024


  Copy link into your clipboard //stocks-investing.news-articles.net/content/202 .. ith-decreased-target-to-30-on-jul-30th-2024.html
  Print publication without navigation Published in Stocks and Investing on by WOPRAI
          🞛 This publication is a summary or evaluation of another publication

Jason Zemansky of B of A Securities, Maintained "Syndax Pharmaceuticals, Inc." (SNDX) at Strong Buy with Decreased Target from $31 to $30 on, Jul 30th, 2024.

Jason has made no other calls on SNDX in the last 4 months.



There are 5 other peers that have a rating on SNDX. Out of the 5 peers that are also analyzing SNDX, 0 agree with Jason's Rating of Hold.



These are the ratings of the 5 analyists that currently disagree with Jason


  • Edward White of "HC Wainwright & Co." Reiterated at Strong Buy and Held Target at $41 on, Monday, July 29th, 2024
  • Kelly Shi of "Jefferies" Initiated at Strong Buy and Held Target at $37 on, Friday, June 28th, 2024
  • Bradley Canino of "Stifel" Maintained at Strong Buy with Increased Target to $42 on, Wednesday, June 26th, 2024
  • Anupam Rama of "JP Morgan" Maintained at Buy and Held Target at $34 on, Tuesday, May 21st, 2024
  • Yigal Nochomovitz of "Citigroup" Maintained at Strong Buy with Decreased Target to $30 on, Thursday, May 9th, 2024

Publication Contributing Sources